Literature DB >> 21880638

Acute myeloid leukemia with expanded erythropoiesis.

Anna Porwit, James W Vardiman.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21880638      PMCID: PMC3166090          DOI: 10.3324/haematol.2011.050526

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  High serum immunoreactive erythropoietin in leukaemic patients with bone marrow insufficiency of erythropoiesis.

Authors:  W Jelkmann; G Wiedemann
Journal:  Eur J Haematol       Date:  1990-11       Impact factor: 2.997

2.  Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.

Authors:  Zeba N Singh; Dezheng Huo; John Anastasi; Sonali M Smith; Theodore Karrison; Michelle M Le Beau; Richard A Larson; James W Vardiman
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

3.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 4.  Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

Authors:  Guido Marcucci; Torsten Haferlach; Hartmut Döhner
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

5.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Authors:  Joshua Wechsler; Marianne Greene; Michael A McDevitt; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

6.  Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

Authors:  Frank Rosenbauer; Katharina Wagner; Jeffery L Kutok; Hiromi Iwasaki; Michelle M Le Beau; Yutaka Okuno; Koichi Akashi; Steven Fiering; Daniel G Tenen
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

7.  Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.

Authors:  O I Olopade; M Thangavelu; R A Larson; R Mick; A Kowal-Vern; H R Schumacher; M M Le Beau; J W Vardiman; J D Rowley
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

8.  Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.

Authors:  Sa A Wang; Guilin Tang; Oluwole Fadare; Suyang Hao; Azra Raza; Bruce A Woda; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2008-09-12       Impact factor: 7.842

9.  Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.

Authors:  Robert P Hasserjian; Zhuang Zuo; Christine Garcia; Guilin Tang; Armen Kasyan; Rajyalakshmi Luthra; Lynne V Abruzzo; Hagop M Kantarjian; L Jeffrey Medeiros; Sa A Wang
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

10.  Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.

Authors:  F P S Santos; S Faderl; G Garcia-Manero; C Koller; M Beran; S O'Brien; S Pierce; E J Freireich; X Huang; G Borthakur; C Bueso-Ramos; M de Lima; M Keating; J Cortes; H Kantarjian; F Ravandi
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

View more
  2 in total

1.  An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.

Authors:  Shaowei Qiu; Erlie Jiang; Hui Wei; Dong Lin; Guangji Zhang; Shuning Wei; Chunlin Zhou; Kaiqi Liu; Ying Wang; Bingcheng Liu; Yuntao Liu; Benfa Gong; Xiaoyuan Gong; Sizhou Feng; Yingchang Mi; Mingzhe Han; Jianxiang Wang
Journal:  BMC Cancer       Date:  2017-08-09       Impact factor: 4.430

2.  The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.

Authors:  Po-Shen Ko; Yao-Chung Liu; Chiu-Mei Yeh; Jyh-Pyng Gau; Yuan-Bin Yu; Liang-Tsai Hsiao; Cheng-Hwai Tzeng; Po-Min Chen; Tzeon-Jye Chiou; Chia-Jen Liu; Jin-Hwang Liu
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.